Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06859710
PHASE1
THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
Sponsor: University of California, Los Angeles
View on ClinicalTrials.gov
Summary
The purpose of this research is to assess the impact of CBD on the effects of THC.
Official title: Interactions Between Delta-9-THC and CBD: A Controlled Human Drug-administration Study Probing a Harm Reduction Strategy
Key Details
Gender
All
Age Range
21 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-11-05
Completion Date
2028-09-01
Last Updated
2025-12-17
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Placebo
Vaporized Placebo
DRUG
THC
Vaporized THC (20 mg)
DRUG
CBD 20 mg
Vaporized CBD (20 mg)
DRUG
CBD 40 mg
Vaporized CBD (40 mg)
DRUG
CBD 80 mg
Vaporized CBD (80 mg)
Locations (1)
UCLA Center for Cannabis and Cannabinoids
Los Angeles, California, United States